Print

Active Implants Corporation Release: NUsurface® Meniscus Clinical Trial Reaches Key Milestone  
1/7/2013 11:07:14 AM

MEMPHIS, Tenn.--(BUSINESS WIRE)--Active Implants Corporation today announces the enrollment of the one hundredth patient in an outside-the-U.S., post-market, prospective, Multi-Center Trial of the NUsurface® Meniscus Implant. The NUsurface® Meniscus Implant is a novel, composite polymer implant which is used to treat knee patients who have pain and disability arising from osteoarthritis (OA) caused by a previous meniscectomy and/or meniscus dysfunction or insufficiency.
//-->